In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Predictors for angiographic edge restenosis of 2nd generation drug-eluting stents: Integrated angiographic analyses from the post-marketing surveillance studies of everolimus-eluting stents in Japan

Session Poster Session 5

Speaker Ken Kozuma

Congress : ESC Congress 2018

  • Topic : interventional cardiology and cardiovascular surgery
  • Sub-topic : Coronary Intervention: Stents
  • Session type : Poster Session
  • FP Number : P4566

Authors : K Kozuma (Tokyo,JP), K Kozuma (Tokyo,JP), T Shinozaki (Tokyo,JP), K Kashiwabara (Tokyo,JP), K Oba (Tokyo,JP), Y Matsuyama (Tokyo,JP)

15 views

Authors:
K. Kozuma1 , K. Kozuma2 , T. Shinozaki1 , K. Kashiwabara1 , K. Oba1 , Y. Matsuyama1 , 1University of Tokyo, Department of Biostatistics, Division of Health Sciences and Nursing Graduate School of Medicine - Tokyo - Japan , 2Teikyo University Hospital, Cardiology - Tokyo - Japan ,

On behalf: Xience PMS Group and PROMUS Element/Element Plus PMS Group

Citation:
European Heart Journal ( 2018 ) 39 ( Supplement ), 934

Purpose: Edge restenosis has gathered focus as a main cause for restenosis after 1st generation drug-eluting stents (DES) implantation. The aim of this study was to assess the incidence of edge restenosis and to detect predictors for edge restenosis after 2nd generation DES implantation in routine clinical practice.

Methods: 2,450 lesions in 2,185 patients from several post marketing surveillances (PMS) of 2nd generation DES, everolimus-eluting etent (EES [Xience V/PROMUS, Xience Prime, Xience Prime SV, Xience Expedition SV, PROMUS Element, PROMUS Element Plus]) at 67 centres in Japan were analysed in this study. In EES PMS in Japan, quantitative coronary angiography (QCA) were conducted in an independent corelab, at pre- and post-procedure and 8–12 months follow-up with subsegmental analysis: in-stent region, proximal and distal edges.

Results: Restenosis rates of in-stent region, proximal and distal edges at follow-up were 4.5%, 2.8% and 1.3%, respectively. Late loss of in-stent region, proximal and distal edges were 0.24±0.43 mm, 0.12±0.41 mm and 0.02±0. 36mm, respectively. Probabilities of restenosis were compared between proximal and distal edges by multivariable adjusted logistic regression models including each lesion as a random effect. Risk of restenosis in distal edge was significantly lower than that in proximal edge (odds ratio [OR] 0.24 95% confidence interval [CI] 0.14 to 0.42 p≤0.001) adjusted with 12 variables as follows: post percent diameter stenosis (%DS), post reference diameter (RD), absolute difference of diameter between stent and vessel, bending >45°, stent overlap, hypertension, previous CABG, previous PCI, hemodialysis, moderate/severe calcification, age and male. Univariate and multivariable analysis of the 12 variables described above were performed in each subsegment. Multivariable analysis showed that post %DS (OR 1.04 95% CI 1.02 to 1.07 p=0.001), post RD (OR 0.50 95% CI 0.34 to 0.75 p≤0.001), stent overlap (OR 1.83 95% CI 1.17 to 2.85 p=0.008), previous CABG (OR 2.21 95% CI 1.15 to 4.28 p=0.02), previous PCI (OR 1.82 95% CI 1.21 to 2.74 p=0.004), hemodialysis (OR 5.13 95% CI 2.79 to 9.41 p≤0.001) and moderate/severe calcification (OR 2.08 95% CI 1.35 to 3.19 p≤0.001) were identified as predictors for in-stent restenosis. In proximal edge, post %DS (OR 1.09 95% CI 1.06 to 1.11 p≤0.001), post RD (OR 0.50 95% CI 0.29 to 0.88 p=0.02), bending >45° (OR 0.08 95% CI 0.01 to 0.62 p=0.02) and hemodiallysis (OR 2.71 95% CI 1.03 to 7.12 p=0.04) were the significant independent predictors, whereas only post %DS (OR 1.07 95% CI 1.04 to 1.11 p≤0.001) was significant in distal edge.

Conclusions: Multivariable analysis of 8–12 months angiographic outcomes from the EES PMS demonstrated higher restenosis risk in proximal edges than distal edges. Post %DS would be a main predictor for edge restenosis in the real-world setting. Edge restenosis might be attributed to angiographic results post-procedure rather than patient backgrounds.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are